Product logins

Find logins to all Clarivate products below.


Facial Injectables | Latin America (Supplemental) | 2016 | Market Analysis

The Latin American market for facial injectables will face somewhat limited procedure volume growth in the short term due to a combination of pricing pressures, poor economic conditions, and low market penetration in some regions. However, as these conditions are alleviated over the forecast period, the market will experience strong growth through 2024.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the facial injectable market in Latin America, including country-level data for seven major countries and aggregate data for the rest of Latin America, across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Latin America
The Latin American IC device market will see strong growth over the forecast period, driven by a rising patient population, the introduction of next-generation devices, and the expanding adoption…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Latin America (Supplemental)
The Latin American EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Latin American countries, improved…
Report
Aesthetic Injectables – Market Insights – Middle East
The Middle Eastern aesthetic injectable market is expected to exhibit rapid growth, driven by the rising awareness and acceptability of these procedures due to the growing influence of social media…
Report
Aesthetic Injectables – Market Insights – Latin America
The Latin American aesthetic injectable market is expected to experience rapid growth through 2034. This expansion will be driven by product development and differentiation efforts from market…
Report
Biosurgical Agents – Market Insights – Latin America (Supplemental)
The biosurgical agent market in Latin America will observe modest growth through 2033, primarily driven by the increasing number of procedures utilizing biosurgical agents, combined with favorable…